Investigation of Risk Factors Related to The Use of Non-Prescription Proton Pump Inhibitors in Patients Referred to A Tertiary Health Care Institution
Research Article
DOI:
https://doi.org/10.5281/zenodo.13384258Keywords:
Proton Pump Inhibitor, Use Of Non-Prescription Drugs, Rational Drug UseAbstract
Introduction: Proton pump inhibitors are benzamidazole derivative drugs that act by inhibiting gastric acid secretion controlled by parietal cells in the gastric epithelium through neuroendocrine pathways. Today, they are widely used worldwide for the treatment of all gastric acid-related diseases, especially gastroesophageal reflux disease.
Objective: It is known that these drugs, which are most commonly prescribed to patients in our society, have recently been prescribed for inappropriate and unnecessary indications as well as over-the-counter use. The aim of this study was to investigate the risk factors related to the use of over-the-counter proton pump inhibitors in outpatients presenting to a tertiary health care centre.
Method: In this cross-sectional and analytical study, a questionnaire was administered face-to-face by the investigators to 300 volunteer patients who applied to the Internal and Surgical Outpatient Clinics of Balıkesir Atatürk City Hospital.
Results: It was found that 115 (38.3%) and 26 (8.7%) of the participants were male. It was found that 283 (94.3%) of the cases were prescription drugs, and when the reasons for use were analysed, it was determined that 116 (38.7%) were multiple drug use and 125 (41.7%) were dyspepsia in the first two. It was determined that an increase in age decreased the risk of using non-prescription proton pump inhibitors at a statistically significant level, and a higher level of education increased the risk of using non-prescription proton pump inhibitors 5.791 times at a statistically significant level.
Conclusion: In this study, it was observed that the use of proton pump inhibitors in patients admitted to outpatient hospitals is extremely common. It is evident that the use of over-the-counter medication has increased recently with off-label prescription. For this reason, it has become imperative to conduct new multicentre studies to examine the use of over-the-counter drugs and the factors affecting this.
References
Yuan J, He Q, Nguyen LH, et al. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies. Gut. 2021;70(6):1070-1077.
Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017;152(4):706-715.
Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153(1):35-48.
Albarki H, Pun A, Paddle PM. What is the truth about proton pump inhibitors?. Current Opinion in Otolaryngology & Head and Neck Surgery. 2020;28(6):376-384.
Wallerstedt SM, Fastbom J, Linke J, et al. Long‐term use of proton pump inhibitors and prevalence of disease‐and drug‐related reasons for gastroprotection-a cross‐sectional population‐based study. Pharmacoepidemiology and Drug Safety. 2017; 26(1): 9-16.
Özdemir B, Ön KB, Altıner E. Uşak Eğitim ve Araştırma Hastanesi’ne Başvuran Hastalarda Proton Pompa İnhibitörü Kullanım Yaygınlığının İncelenmesi. Ege Tıp Bilimleri Dergisi. 2022;5(1):11-15.
Ozdinc S, Sensoy N, Kurt R, Altas S, Altun R. Are we using drugs rationally? A survey study from Turkey. Pakistan journal of medical sciences. 2015;31(5):1156.
Özden A. Proton pompa inhibitörleri ve kullanım güvenirliği. Güncel Gastroenteroloji Dergisi. 2013;17;179-204.
Savarino V, Marabotto E, Zentilin P, et al. The appropriate use of proton-pump inhibitors. Minerva Medica. 2018;109(5):386-399.
Savarino V, Marabotto E, Zentilin P, et al. Proton pump inhibitors: use and misuse in the clinical setting. Expert review of clinical pharmacology. 2018;11(11):1123-1134.
Castellana C, Pecere S, Furnari M, et al. Side effects of long-term use of proton pump inhibitors: practical considerations. Pol Arch Intern Med. 2021;131(6):541-549.
Dutta AK, Jain A, Jearth V, et al. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship. Indian Journal of Gastroenterology. 2023;42(5):601-628.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Acta Medica Ruha
This work is licensed under a Creative Commons Attribution 4.0 International License.